Approval · Notice of Compliance 18985 · 2017
OXYTROL: Notice of Compliance 18985
Issued February 16, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18985
- Date
- February 16, 2017
- Company
- Allergan Pharma Co.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph in response to an advisement letter dated october 7, 2016
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXYTROL | 02254735 | Cancelled Post Market |
Medicinal ingredients
- OXYBUTYNIN 36 MG per MG